MA39289A - Formulations pharmaceutiques de vilanterol - Google Patents

Formulations pharmaceutiques de vilanterol

Info

Publication number
MA39289A
MA39289A MA039289A MA39289A MA39289A MA 39289 A MA39289 A MA 39289A MA 039289 A MA039289 A MA 039289A MA 39289 A MA39289 A MA 39289A MA 39289 A MA39289 A MA 39289A
Authority
MA
Morocco
Prior art keywords
vilanterol
pharmaceutical formulations
formulation
bpco
prophylaxis
Prior art date
Application number
MA039289A
Other languages
English (en)
Inventor
Özlem Akdas
Devrim Celik
Ali Türkyilmaz
Original Assignee
Arven Ilac Sanayi Ve Ticaret As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from TR2014/07010A external-priority patent/TR201407010A2/tr
Application filed by Arven Ilac Sanayi Ve Ticaret As filed Critical Arven Ilac Sanayi Ve Ticaret As
Publication of MA39289A publication Critical patent/MA39289A/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention se rapporte à une formulation pharmaceutique pour inhalation comprenant vilanterol en tant qu'agent actif, un excipient et du stéarate de magnésium dans le traitement et la prophylaxie des maladies respiratoires telles que l'asthme, la broncho-pneumopathie chronique obstructive (bpco), ainsi qu'à un procédé pour produire ce formulation.
MA039289A 2014-06-16 2015-06-15 Formulations pharmaceutiques de vilanterol MA39289A (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
TR201406982 2014-06-16
TR201407012 2014-06-17
TR201407009 2014-06-17
TR2014/07010A TR201407010A2 (tr) 2014-06-16 2014-06-17 Vilanterol formülasyonları.

Publications (1)

Publication Number Publication Date
MA39289A true MA39289A (fr) 2015-12-23

Family

ID=77631531

Family Applications (1)

Application Number Title Priority Date Filing Date
MA039289A MA39289A (fr) 2014-06-16 2015-06-15 Formulations pharmaceutiques de vilanterol

Country Status (1)

Country Link
MA (1) MA39289A (fr)

Similar Documents

Publication Publication Date Title
CY1123391T1 (el) (2s)-n-[(1s)-1-kyano-2-φainyλaιθyλ]-1,4-oξazeπan-2-καρβοξαμιδια ως αναστολεις της διπεπτιδυλικης πεπτιδασης ι
MX2019003397A (es) Metodos para tratar trastornos mitocondriales y metabolicos.
BR112018010650A2 (pt) pró-fármacos de um inibidor de jak composto para o tratamento da doença inflamatória gastrointestinal
MX2014013523A (es) Preparaciones de agentes terapeuticos hidrofobos, metodos de elaboracion y uso de los mismos.
BR112017010551A2 (pt) composto, métodos para ativação de guanilato ciclase solúvel, para tratamento de uma ou mais condições selecionadas a partir de uma doença em um paciente e para tratamento de uma doença ou condição, composição farmacêutica, uso de um composto, e, medicamento.
PH12017502087B1 (en) Tiotropium inhalation solution for nebulization
MA39725B1 (fr) Compositions pharmaceutiques de composés thérapeutiquement actifs
BR112015018168A2 (pt) inibidores de rock suaves
EA201800499A1 (ru) Ингибитор тирозинкиназы для лечения амиотрофного латерального склероза, композиция, лекарственное средство, набор
MX2018006247A (es) Metodos para tratar la enfermedad de alzheimer y trastornos relacionados.
EP4364801A3 (fr) Dosage optimisé de diaminophénothiazines dans des populations
WO2014016548A3 (fr) Composition pharmaceutique
EA201891931A1 (ru) Новые ингибиторы фосфатидилинозитол-3-киназы гамма
MA38646A1 (fr) Formulation a liberation modifiee pour traiter, par ex. La maladie de parkinson et la dyskinesie induite par l-dopa.
MA39447A1 (fr) (s)-pirlindole ou ses sels pharmaceutiquement acceptables pour une utilisation en médecine
MA39448A1 (fr) (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical
NZ708526A (en) Novel rock inhibitors
MA39288A (fr) Formulations pharmaceutiques comprenant du vilanterol
MA39289A (fr) Formulations pharmaceutiques de vilanterol
EA201890789A1 (ru) Содержащая цинеол композиция для лечения заболеваний носа
MA54630B1 (fr) N,n-bis-2-mercaptoéthyle isophtalamide pour le traitement des maladies neurodégénératives
MX2021014093A (es) Composiciones y metodos para tratar el mal de alzheimer y la enfermedad de parkinson.
Toellner et al. C38 UNDERSTANDING THERAPEUTICS IN IPF: Clinical Experience With Nintedanib For Idiopathic Pulmonary Fibrosis In 3 Uk Tertiary Interstitial Lung Disease Centres
TR201716203A1 (tr) Yeni umeklidinyum formülasyonları.
TH170136B (th) อินดาโซลคาร์บอกซาไมด์แบบใหม่ กระบวนการในการเตรียมสารดังกล่าว ยาเตรียม ทางเภสัชกรรมซึ่งประกอบรวมด้วยสารดังกล่าว และการใช้สารดังกล่าว ในการผลิตยารักษาโรค